SCHEMBL19487117

SCHEMBL19487117

C=N/C(=C\C=C/C)c1ccc(C(C)(C)c2ccc(-c3cc(-c4ccccc4)nc(-c4ccccc4)n3)cc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 8/20 0.41
▸ KMT2A Q03164 8/20 0.41
▸ NTSR1 P30989 2/20 0.41
▸ MAPT P10636 7/20 0.40
▸ ALDH1A1 P00352 6/20 0.40
▸ HPGD P15428 6/20 0.40
▸ KDM4E B2RXH2 4/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ RXFP1 Q9HBX9 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ ADORA1 P30542 8/20 0.39
▸ LMNA P02545 3/20 0.36
▸ HTT P42858 1/20 0.36
▸ ATM Q13315 1/20 0.36
▸ ADORA3 P0DMS8 7/20 0.36
▸ ADORA2A P29274 3/20 0.36
▸ GLA P06280 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25942238 0.93 RXRA (0.34) MAPTALDH1A1HPGDKDM4EADORA1
SCHEMBL17725543 0.78 MEN1 (0.59) MEN1KMT2ANTSR1MAPTALDH1A1
SCHEMBL17725330 0.78 MEN1 (0.59) MEN1KMT2ANTSR1MAPTALDH1A1
SCHEMBL19053749 0.77 MAPK8 (0.34) MEN1KMT2ANTSR1MAPTALDH1A1
SCHEMBL25987125 0.77 MCL1 (0.36) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL17725286 0.76 MEN1 (0.58) MEN1KMT2ANTSR1MAPTALDH1A1
SCHEMBL17725241 0.76 MEN1 (0.58) MEN1KMT2ANTSR1MAPTALDH1A1
SCHEMBL17725326 0.76 MEN1 (0.58) MEN1KMT2ANTSR1MAPTALDH1A1
SCHEMBL17725256 0.76 MEN1 (0.62) MEN1KMT2ANTSR1MAPTALDH1A1
SCHEMBL17725260 0.76 MEN1 (0.58) MEN1KMT2ANTSR1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10431748-B2 Cyclic compound and organic light-emitting element comprising same LG CHEM, LTD. (KR) 2019-10-01 — — US disclosed
US-20170301866-A1 CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2017-10-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170301866-A1 CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, PER2 MEN1 599/4885KMT2A 1068/4885NTSR1 4837/4885
US-10431748-B2 Cyclic compound and organic light-emitting element comprising same CRY1, CRY2, PER2 MEN1 599/4885KMT2A 1068/4885NTSR1 4837/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback